Adventrx Pharmaceuticals, Inc.
Records under this name other than patents Adventrx Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Adventrx Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,470,873 | Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof Formerly held In force (reinstated) · USPTO record | In force (reinstated) | USPTO record | |
| US 8,557,861 | Low oil emulsion compositions for delivering taxoids and other insoluble drugs Formerly held Lapsed on the fee record Ended Oct 15, 2025 · USPTO record | Lapsed on the fee record | Ended Oct 15, 2025 | USPTO record |
| US 8,470,346 | Anti-viral pharmaceutical compositions Formerly held Term ended Ended no later than Dec 3, 2024 · USPTO record | Term ended | Ended no later than Dec 3, 2024 | USPTO record |
| US 8,026,250 | Compositions for delivering highly water soluble drugs Formerly held Lapsed on the fee record Ended Sep 27, 2019 · USPTO record | Lapsed on the fee record | Ended Sep 27, 2019 | USPTO record |
| US 7,968,122 | Anti-viral pharmaceutical compositions Formerly held Lapsed on the fee record Ended Jun 28, 2019 · USPTO record | Lapsed on the fee record | Ended Jun 28, 2019 | USPTO record |
| US 7,871,632 | Compositions for delivering highly water soluble drugs Formerly held Lapsed on the fee record Ended Jan 18, 2019 · USPTO record | Lapsed on the fee record | Ended Jan 18, 2019 | USPTO record |
| US 8,222,268 | Methods for reducing vein irritation Formerly held Lapsed on the fee record Ended Jul 17, 2016 · USPTO record | Lapsed on the fee record | Ended Jul 17, 2016 | USPTO record |